Life sciences news
-
Flamingo Therapeutics expands alliance with Ionis Pharmaceuticals to develop RNA-targeted therapies for oncology
Thursday September 9th 2021
Read more
-
Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases
Thursday September 9th 2021
Read more
-
ViroVet and The Pirbright Institute are first to demonstrate efficacy of antivirals in ASFV infected pigs
Thursday September 9th 2021
Read more
-
Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities
Monday September 6th 2021
Read more
-
Novalis Biotech Acceleration invests in San Francisco-based Modality.AI - technology that ‘self-drives’ neurological and psychiatric assessments
Friday September 3rd 2021
Read more
-
Quality by Design zet nieuwe stap in groeiverhaal: Qarad vervoegt QbD Group
Thursday September 2nd 2021
Read more
-
Biocartis launches Idylla™ SARS-CoV-2/Flu/RSV Panel
Thursday September 2nd 2021
Read more
-
ExeVir announces first patient enrolled in phase 1b/2 clinical study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19
Wednesday September 1st 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos announces planned retirement of CEO
Tuesday August 31st 2021
Read more
-
Sequana Medical appoints Jackie Fielding, former Medtronic VP, to its Board of Directors
Tuesday August 31st 2021
Read more
-
Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004
Monday August 30th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
